Reid Landes
Concepts (373)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Research Design | 5 | 2024 | 344 | 1.560 |
Why?
| Radiation-Protective Agents | 4 | 2021 | 74 | 1.270 |
Why?
| Gait Disorders, Neurologic | 3 | 2024 | 36 | 1.210 |
Why?
| Sample Size | 3 | 2023 | 37 | 1.160 |
Why?
| Parkinson Disease | 3 | 2024 | 154 | 1.090 |
Why?
| Random Allocation | 2 | 2024 | 281 | 1.060 |
Why?
| Reward | 10 | 2013 | 110 | 0.940 |
Why?
| Smoking | 8 | 2015 | 511 | 0.890 |
Why?
| Radiation Injuries | 2 | 2023 | 113 | 0.890 |
Why?
| Antipsychotic Agents | 4 | 2014 | 232 | 0.860 |
Why?
| Impulsive Behavior | 9 | 2015 | 77 | 0.830 |
Why?
| Opioid-Related Disorders | 6 | 2023 | 381 | 0.800 |
Why?
| Heart Diseases | 1 | 2023 | 206 | 0.750 |
Why?
| Heart | 7 | 2023 | 326 | 0.740 |
Why?
| Models, Psychological | 3 | 2017 | 75 | 0.680 |
Why?
| Health Services Needs and Demand | 1 | 2020 | 158 | 0.660 |
Why?
| Oxygen | 5 | 2023 | 326 | 0.650 |
Why?
| Clinical Trials as Topic | 2 | 2020 | 461 | 0.650 |
Why?
| Toxicology | 1 | 2018 | 28 | 0.640 |
Why?
| Data Interpretation, Statistical | 4 | 2024 | 158 | 0.610 |
Why?
| Tobacco Use Disorder | 7 | 2015 | 168 | 0.610 |
Why?
| Humans | 63 | 2024 | 49974 | 0.600 |
Why?
| Animals | 23 | 2024 | 13187 | 0.580 |
Why?
| Male | 54 | 2024 | 25241 | 0.560 |
Why?
| Protons | 3 | 2023 | 69 | 0.540 |
Why?
| Radiation Protection | 2 | 2013 | 47 | 0.530 |
Why?
| Confidence Intervals | 3 | 2013 | 156 | 0.500 |
Why?
| Social Behavior | 2 | 2012 | 72 | 0.490 |
Why?
| Heart Defects, Congenital | 1 | 2020 | 595 | 0.480 |
Why?
| Drug Evaluation, Preclinical | 2 | 2012 | 144 | 0.470 |
Why?
| Amphetamine-Related Disorders | 2 | 2012 | 94 | 0.470 |
Why?
| Female | 47 | 2024 | 26472 | 0.460 |
Why?
| Animal Welfare | 1 | 2013 | 7 | 0.460 |
Why?
| Methamphetamine | 3 | 2012 | 200 | 0.460 |
Why?
| Psychotic Disorders | 2 | 2014 | 133 | 0.440 |
Why?
| Guidelines as Topic | 1 | 2013 | 111 | 0.430 |
Why?
| Motivation | 6 | 2019 | 273 | 0.430 |
Why?
| Evidence-Based Practice | 1 | 2013 | 96 | 0.430 |
Why?
| Cognition Disorders | 5 | 2015 | 218 | 0.430 |
Why?
| Smoking Cessation | 6 | 2015 | 299 | 0.410 |
Why?
| Cosmic Radiation | 2 | 2023 | 31 | 0.410 |
Why?
| Adult | 27 | 2024 | 13236 | 0.410 |
Why?
| Proportional Hazards Models | 2 | 2014 | 402 | 0.400 |
Why?
| Behavior, Addictive | 2 | 2011 | 58 | 0.400 |
Why?
| Intestine, Small | 3 | 2021 | 109 | 0.400 |
Why?
| Quality Improvement | 1 | 2013 | 208 | 0.390 |
Why?
| Radiation Injuries, Experimental | 1 | 2012 | 81 | 0.390 |
Why?
| Radiation, Ionizing | 4 | 2021 | 100 | 0.390 |
Why?
| Herbicide Resistance | 1 | 2011 | 3 | 0.390 |
Why?
| Crops, Agricultural | 1 | 2011 | 7 | 0.380 |
Why?
| Shikimic Acid | 1 | 2011 | 4 | 0.380 |
Why?
| Lethal Dose 50 | 3 | 2018 | 12 | 0.380 |
Why?
| Spectrophotometry | 1 | 2011 | 33 | 0.380 |
Why?
| Probability | 4 | 2018 | 164 | 0.380 |
Why?
| Substance Withdrawal Syndrome | 1 | 2012 | 169 | 0.370 |
Why?
| Buprenorphine | 4 | 2023 | 140 | 0.370 |
Why?
| Glycine | 1 | 2011 | 75 | 0.370 |
Why?
| Survival Analysis | 1 | 2012 | 653 | 0.360 |
Why?
| Individuality | 1 | 2010 | 30 | 0.350 |
Why?
| Cognition | 5 | 2019 | 338 | 0.350 |
Why?
| Psychometrics | 2 | 2010 | 224 | 0.340 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2011 | 349 | 0.340 |
Why?
| Computer Simulation | 3 | 2020 | 280 | 0.340 |
Why?
| Metabolic Diseases | 2 | 2023 | 40 | 0.330 |
Why?
| Dementia | 4 | 2014 | 141 | 0.330 |
Why?
| Choice Behavior | 5 | 2013 | 85 | 0.320 |
Why?
| Satiation | 1 | 2008 | 8 | 0.320 |
Why?
| Plant Extracts | 1 | 2011 | 190 | 0.320 |
Why?
| Central Nervous System Stimulants | 3 | 2008 | 213 | 0.320 |
Why?
| Time Factors | 11 | 2017 | 2903 | 0.320 |
Why?
| Young Adult | 11 | 2023 | 3958 | 0.320 |
Why?
| Nicotine | 2 | 2009 | 187 | 0.310 |
Why?
| Nuclear Weapons | 2 | 2019 | 4 | 0.300 |
Why?
| Middle Aged | 24 | 2024 | 12069 | 0.300 |
Why?
| Executive Function | 3 | 2015 | 76 | 0.300 |
Why?
| Quality Assurance, Health Care | 1 | 2008 | 149 | 0.290 |
Why?
| Time Perception | 3 | 2017 | 29 | 0.290 |
Why?
| Health Behavior | 2 | 2020 | 254 | 0.290 |
Why?
| Guideline Adherence | 1 | 2008 | 133 | 0.290 |
Why?
| Schizophrenia | 1 | 2008 | 256 | 0.280 |
Why?
| Dose-Response Relationship, Radiation | 5 | 2023 | 184 | 0.270 |
Why?
| DNA Methylation | 3 | 2022 | 548 | 0.270 |
Why?
| Mice | 13 | 2023 | 5739 | 0.260 |
Why?
| Levodopa | 2 | 2023 | 42 | 0.260 |
Why?
| Quality of Life | 2 | 2022 | 836 | 0.260 |
Why?
| Cocaine-Related Disorders | 3 | 2014 | 205 | 0.250 |
Why?
| Decision Making | 5 | 2015 | 265 | 0.250 |
Why?
| Exercise | 3 | 2023 | 495 | 0.250 |
Why?
| Opiate Substitution Treatment | 3 | 2023 | 89 | 0.250 |
Why?
| Animals, Laboratory | 1 | 2024 | 6 | 0.250 |
Why?
| Gait | 2 | 2023 | 85 | 0.250 |
Why?
| Housing, Animal | 1 | 2024 | 15 | 0.250 |
Why?
| Mice, Inbred C57BL | 9 | 2022 | 1816 | 0.240 |
Why?
| Disease Progression | 2 | 2024 | 825 | 0.240 |
Why?
| Rats | 6 | 2023 | 3305 | 0.240 |
Why?
| Writing | 1 | 2024 | 43 | 0.240 |
Why?
| Aged | 18 | 2024 | 9310 | 0.230 |
Why?
| Biological Factors | 1 | 2023 | 10 | 0.230 |
Why?
| Anti-Asthmatic Agents | 1 | 2023 | 30 | 0.220 |
Why?
| Heart Atria | 1 | 2023 | 55 | 0.220 |
Why?
| Radiation Dosage | 4 | 2021 | 157 | 0.220 |
Why?
| Tai Ji | 1 | 2023 | 22 | 0.220 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2020 | 488 | 0.220 |
Why?
| Feasibility Studies | 2 | 2023 | 375 | 0.210 |
Why?
| Socioeconomic Factors | 3 | 2020 | 581 | 0.210 |
Why?
| Metformin | 1 | 2023 | 64 | 0.210 |
Why?
| Transcranial Magnetic Stimulation | 2 | 2013 | 70 | 0.210 |
Why?
| Space Flight | 2 | 2019 | 34 | 0.210 |
Why?
| Severity of Illness Index | 2 | 2024 | 945 | 0.210 |
Why?
| Models, Statistical | 3 | 2013 | 224 | 0.200 |
Why?
| Dose-Response Relationship, Drug | 2 | 2018 | 1376 | 0.200 |
Why?
| Spleen | 2 | 2020 | 172 | 0.200 |
Why?
| Lymphocytes | 1 | 2022 | 152 | 0.200 |
Why?
| Duodenum | 1 | 2021 | 35 | 0.200 |
Why?
| Biomedical Research | 1 | 2024 | 237 | 0.190 |
Why?
| Reproducibility of Results | 2 | 2023 | 1193 | 0.190 |
Why?
| Protein C | 1 | 2021 | 18 | 0.190 |
Why?
| Ions | 4 | 2023 | 33 | 0.190 |
Why?
| Social Class | 2 | 2012 | 94 | 0.190 |
Why?
| Jejunum | 1 | 2021 | 54 | 0.190 |
Why?
| Universities | 2 | 2024 | 161 | 0.190 |
Why?
| Ileum | 1 | 2021 | 89 | 0.190 |
Why?
| Odds Ratio | 3 | 2018 | 545 | 0.190 |
Why?
| Hospitals, Veterans | 2 | 2013 | 110 | 0.190 |
Why?
| Bayes Theorem | 2 | 2018 | 109 | 0.190 |
Why?
| Chromosome Aberrations | 1 | 2022 | 297 | 0.180 |
Why?
| Survivors | 2 | 2019 | 126 | 0.180 |
Why?
| Weightlessness Simulation | 1 | 2020 | 19 | 0.180 |
Why?
| Thymus Gland | 1 | 2020 | 42 | 0.180 |
Why?
| Gamma Rays | 1 | 2020 | 49 | 0.180 |
Why?
| Amitriptyline | 1 | 2020 | 13 | 0.180 |
Why?
| Home Care Agencies | 1 | 2020 | 6 | 0.180 |
Why?
| Aorta, Abdominal | 1 | 2020 | 41 | 0.180 |
Why?
| Insulin Resistance | 1 | 2022 | 264 | 0.180 |
Why?
| Fibromyalgia | 1 | 2020 | 17 | 0.180 |
Why?
| Aged, 80 and over | 11 | 2019 | 3129 | 0.180 |
Why?
| Psychological Tests | 2 | 2017 | 50 | 0.180 |
Why?
| Adolescent | 10 | 2023 | 6356 | 0.170 |
Why?
| Healthcare Disparities | 2 | 2014 | 257 | 0.170 |
Why?
| Asthma | 1 | 2023 | 281 | 0.170 |
Why?
| Monte Carlo Method | 1 | 2020 | 84 | 0.170 |
Why?
| Quality Indicators, Health Care | 1 | 2020 | 86 | 0.170 |
Why?
| Phenotype | 1 | 2022 | 729 | 0.170 |
Why?
| Adaptation, Psychological | 1 | 2020 | 224 | 0.170 |
Why?
| Oxygen Radioisotopes | 1 | 2019 | 14 | 0.160 |
Why?
| Arkansas | 8 | 2022 | 1977 | 0.160 |
Why?
| Home Care Services | 1 | 2020 | 73 | 0.160 |
Why?
| Thigh | 1 | 2018 | 34 | 0.160 |
Why?
| Analysis of Variance | 2 | 2017 | 562 | 0.160 |
Why?
| User-Computer Interface | 1 | 2018 | 81 | 0.160 |
Why?
| Cardiovascular Diseases | 1 | 2023 | 440 | 0.150 |
Why?
| Skin | 1 | 2021 | 409 | 0.150 |
Why?
| Weight Gain | 2 | 2022 | 240 | 0.150 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 2018 | 106 | 0.150 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2017 | 38 | 0.150 |
Why?
| Drug Monitoring | 2 | 2014 | 77 | 0.140 |
Why?
| Intention | 1 | 2017 | 43 | 0.140 |
Why?
| Gene Expression | 2 | 2019 | 609 | 0.140 |
Why?
| Whole-Body Irradiation | 2 | 2021 | 131 | 0.140 |
Why?
| Directive Counseling | 2 | 2014 | 23 | 0.140 |
Why?
| Telephone | 2 | 2014 | 70 | 0.140 |
Why?
| United States | 5 | 2020 | 4860 | 0.140 |
Why?
| Myocardium | 1 | 2019 | 436 | 0.140 |
Why?
| Tomography, X-Ray Computed | 2 | 2019 | 1159 | 0.140 |
Why?
| Depressive Disorder | 2 | 2009 | 339 | 0.140 |
Why?
| Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 21 | 0.130 |
Why?
| Body Weight | 2 | 2020 | 513 | 0.130 |
Why?
| Gene Duplication | 1 | 2015 | 15 | 0.130 |
Why?
| Hematopoietic Stem Cells | 1 | 2017 | 184 | 0.130 |
Why?
| Green Fluorescent Proteins | 1 | 2015 | 90 | 0.130 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2015 | 38 | 0.120 |
Why?
| Students | 1 | 2017 | 210 | 0.120 |
Why?
| Liver | 3 | 2023 | 1115 | 0.120 |
Why?
| Hyperlipidemias | 1 | 2014 | 49 | 0.120 |
Why?
| Alzheimer Disease | 2 | 2009 | 324 | 0.120 |
Why?
| Educational Status | 4 | 2015 | 222 | 0.120 |
Why?
| Conditioning, Operant | 1 | 2015 | 116 | 0.120 |
Why?
| Hyperglycemia | 1 | 2014 | 79 | 0.120 |
Why?
| Biofeedback, Psychology | 1 | 2013 | 17 | 0.110 |
Why?
| Electric Stimulation | 1 | 2013 | 118 | 0.110 |
Why?
| Databases, Factual | 2 | 2013 | 658 | 0.110 |
Why?
| Medical Records | 1 | 2013 | 83 | 0.110 |
Why?
| Sexual Behavior | 1 | 2014 | 117 | 0.110 |
Why?
| Eye Diseases | 1 | 2013 | 38 | 0.110 |
Why?
| Cluster Analysis | 1 | 2013 | 235 | 0.110 |
Why?
| Cross-Sectional Studies | 4 | 2024 | 1557 | 0.110 |
Why?
| Physicians, Primary Care | 1 | 2013 | 44 | 0.110 |
Why?
| Pain | 2 | 2023 | 379 | 0.110 |
Why?
| Cholesterol, LDL | 1 | 2013 | 34 | 0.110 |
Why?
| Japan | 3 | 2019 | 26 | 0.110 |
Why?
| Sex Characteristics | 1 | 2014 | 190 | 0.110 |
Why?
| Diabetes Complications | 1 | 2013 | 118 | 0.110 |
Why?
| Longitudinal Studies | 3 | 2024 | 688 | 0.100 |
Why?
| Animal Experimentation | 1 | 2012 | 3 | 0.100 |
Why?
| Internal-External Control | 1 | 2012 | 31 | 0.100 |
Why?
| Internet | 1 | 2014 | 259 | 0.100 |
Why?
| Psychiatric Status Rating Scales | 2 | 2014 | 319 | 0.100 |
Why?
| Aggression | 2 | 2011 | 49 | 0.100 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 194 | 0.100 |
Why?
| Community Networks | 1 | 2012 | 50 | 0.100 |
Why?
| Commodification | 1 | 2011 | 2 | 0.100 |
Why?
| Treatment Outcome | 7 | 2018 | 5141 | 0.100 |
Why?
| Qualitative Research | 1 | 2013 | 329 | 0.100 |
Why?
| Veterans | 2 | 2018 | 555 | 0.100 |
Why?
| Herbicides | 1 | 2011 | 12 | 0.100 |
Why?
| Receptors, Steroid | 1 | 2010 | 19 | 0.090 |
Why?
| Adolescent Behavior | 1 | 2011 | 101 | 0.090 |
Why?
| Kaplan-Meier Estimate | 1 | 2012 | 466 | 0.090 |
Why?
| Education | 1 | 2010 | 41 | 0.090 |
Why?
| Psychomotor Agitation | 1 | 2011 | 51 | 0.090 |
Why?
| Cytochrome P-450 CYP3A | 1 | 2010 | 78 | 0.090 |
Why?
| Antibodies, Monoclonal | 2 | 2005 | 459 | 0.090 |
Why?
| Meta-Analysis as Topic | 1 | 2010 | 39 | 0.090 |
Why?
| Clinical Competence | 1 | 2013 | 393 | 0.090 |
Why?
| Dexamethasone | 2 | 2010 | 430 | 0.090 |
Why?
| Attitude of Health Personnel | 1 | 2013 | 347 | 0.090 |
Why?
| Blood Glucose | 1 | 2013 | 439 | 0.090 |
Why?
| Memory, Short-Term | 1 | 2010 | 73 | 0.090 |
Why?
| Aging | 1 | 2015 | 687 | 0.090 |
Why?
| Marijuana Abuse | 1 | 2011 | 147 | 0.090 |
Why?
| Mutation | 1 | 2015 | 1294 | 0.080 |
Why?
| Extinction, Psychological | 1 | 2009 | 33 | 0.080 |
Why?
| Apolipoprotein E4 | 1 | 2009 | 19 | 0.080 |
Why?
| Logistic Models | 4 | 2014 | 888 | 0.080 |
Why?
| Ophthalmic Solutions | 1 | 2009 | 18 | 0.080 |
Why?
| Diphenhydramine | 1 | 2009 | 19 | 0.080 |
Why?
| Anesthesia, Local | 1 | 2009 | 15 | 0.080 |
Why?
| Soybean Proteins | 1 | 2010 | 161 | 0.080 |
Why?
| Cornea | 1 | 2009 | 52 | 0.080 |
Why?
| Epigenesis, Genetic | 2 | 2022 | 374 | 0.080 |
Why?
| Multivariate Analysis | 3 | 2017 | 577 | 0.080 |
Why?
| Anesthetics, Local | 1 | 2009 | 75 | 0.080 |
Why?
| Promoter Regions, Genetic | 1 | 2010 | 475 | 0.080 |
Why?
| Health Care Surveys | 1 | 2008 | 173 | 0.080 |
Why?
| Analgesics, Opioid | 3 | 2023 | 552 | 0.070 |
Why?
| Models, Biological | 1 | 2011 | 727 | 0.070 |
Why?
| Child | 4 | 2023 | 6847 | 0.070 |
Why?
| Analgesics | 1 | 2008 | 100 | 0.070 |
Why?
| Rabbits | 2 | 2023 | 370 | 0.070 |
Why?
| Mental Competency | 1 | 2007 | 33 | 0.070 |
Why?
| Sex Factors | 3 | 2015 | 691 | 0.070 |
Why?
| Informed Consent | 1 | 2007 | 96 | 0.070 |
Why?
| Antibody Affinity | 1 | 2005 | 7 | 0.070 |
Why?
| Practice Guidelines as Topic | 1 | 2008 | 449 | 0.060 |
Why?
| Faculty | 1 | 2024 | 72 | 0.060 |
Why?
| Activities of Daily Living | 2 | 2020 | 174 | 0.060 |
Why?
| Research Personnel | 1 | 2024 | 66 | 0.060 |
Why?
| Neuropsychological Tests | 3 | 2011 | 353 | 0.060 |
Why?
| Mental Disorders | 1 | 2008 | 396 | 0.060 |
Why?
| Single-Blind Method | 2 | 2013 | 116 | 0.050 |
Why?
| Program Evaluation | 1 | 2024 | 354 | 0.050 |
Why?
| Adrenal Cortex Hormones | 1 | 2023 | 94 | 0.050 |
Why?
| Prefrontal Cortex | 2 | 2013 | 82 | 0.050 |
Why?
| Token Economy | 2 | 2014 | 33 | 0.050 |
Why?
| Cytogenetic Analysis | 1 | 2022 | 82 | 0.050 |
Why?
| Methadone | 1 | 2023 | 172 | 0.050 |
Why?
| Alendronate | 1 | 2002 | 23 | 0.050 |
Why?
| Combined Modality Therapy | 2 | 2014 | 637 | 0.050 |
Why?
| Risk Factors | 3 | 2019 | 3613 | 0.050 |
Why?
| Leukocytes, Mononuclear | 1 | 2022 | 116 | 0.050 |
Why?
| Primates | 1 | 2021 | 20 | 0.050 |
Why?
| Macaca mulatta | 1 | 2021 | 93 | 0.050 |
Why?
| Chromans | 1 | 2021 | 37 | 0.050 |
Why?
| Immunoblotting | 1 | 2021 | 118 | 0.050 |
Why?
| Overweight | 1 | 2023 | 219 | 0.050 |
Why?
| Vitamin E | 1 | 2021 | 81 | 0.050 |
Why?
| Catecholamines | 1 | 2020 | 46 | 0.050 |
Why?
| Drinking | 1 | 2020 | 38 | 0.050 |
Why?
| Interviews as Topic | 2 | 2012 | 259 | 0.050 |
Why?
| Rats, Long-Evans | 1 | 2020 | 26 | 0.050 |
Why?
| Intestines | 1 | 2021 | 176 | 0.040 |
Why?
| Glucocorticoids | 1 | 2002 | 219 | 0.040 |
Why?
| Policy | 1 | 2020 | 24 | 0.040 |
Why?
| Intestinal Mucosa | 1 | 2021 | 225 | 0.040 |
Why?
| Retrospective Studies | 3 | 2020 | 6108 | 0.040 |
Why?
| Genotype | 1 | 2021 | 537 | 0.040 |
Why?
| Area Under Curve | 2 | 2015 | 182 | 0.040 |
Why?
| Heart Rate | 1 | 2021 | 293 | 0.040 |
Why?
| Insulin | 1 | 2022 | 457 | 0.040 |
Why?
| Energy Intake | 1 | 2020 | 170 | 0.040 |
Why?
| Age Factors | 2 | 2015 | 1087 | 0.040 |
Why?
| DNA, Satellite | 1 | 2019 | 11 | 0.040 |
Why?
| Centromere | 1 | 2019 | 11 | 0.040 |
Why?
| Stress, Physiological | 1 | 2020 | 170 | 0.040 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2019 | 96 | 0.040 |
Why?
| Carbon | 1 | 2019 | 54 | 0.040 |
Why?
| Metabolic Networks and Pathways | 1 | 2019 | 89 | 0.040 |
Why?
| Osteoclasts | 1 | 2002 | 425 | 0.040 |
Why?
| Rats, Sprague-Dawley | 3 | 2010 | 1597 | 0.040 |
Why?
| Immunohistochemistry | 1 | 2021 | 973 | 0.040 |
Why?
| Methionine | 1 | 2019 | 135 | 0.040 |
Why?
| Organ Size | 1 | 2018 | 226 | 0.040 |
Why?
| Medicare | 1 | 2020 | 246 | 0.040 |
Why?
| Psychological Theory | 1 | 2017 | 23 | 0.040 |
Why?
| Resistance Training | 1 | 2018 | 92 | 0.040 |
Why?
| Emotions | 1 | 2019 | 165 | 0.040 |
Why?
| Retroelements | 1 | 2017 | 14 | 0.040 |
Why?
| Mice, Inbred CBA | 1 | 2017 | 35 | 0.040 |
Why?
| Apoptosis | 2 | 2019 | 1101 | 0.040 |
Why?
| Hematopoiesis | 1 | 2017 | 71 | 0.040 |
Why?
| Species Specificity | 1 | 2017 | 192 | 0.040 |
Why?
| Adipose Tissue | 1 | 2018 | 187 | 0.040 |
Why?
| Gene Knock-In Techniques | 1 | 2015 | 22 | 0.030 |
Why?
| Genes | 1 | 2015 | 33 | 0.030 |
Why?
| Age Distribution | 1 | 2015 | 168 | 0.030 |
Why?
| DNA Damage | 1 | 2017 | 301 | 0.030 |
Why?
| Pancreas | 1 | 2015 | 70 | 0.030 |
Why?
| Exons | 1 | 2015 | 95 | 0.030 |
Why?
| Rural Population | 1 | 2020 | 540 | 0.030 |
Why?
| Bone and Bones | 1 | 2018 | 469 | 0.030 |
Why?
| Antibody Specificity | 2 | 2005 | 36 | 0.030 |
Why?
| Infant | 1 | 2023 | 3567 | 0.030 |
Why?
| Risk Assessment | 1 | 2019 | 1259 | 0.030 |
Why?
| Control Groups | 1 | 2013 | 9 | 0.030 |
Why?
| Obesity | 1 | 2022 | 1113 | 0.030 |
Why?
| Mice, Inbred BALB C | 2 | 2005 | 304 | 0.030 |
Why?
| Narcotic Antagonists | 1 | 2014 | 135 | 0.030 |
Why?
| Residence Characteristics | 1 | 2014 | 151 | 0.030 |
Why?
| Gambling | 1 | 2013 | 18 | 0.030 |
Why?
| Ophthalmology | 1 | 2013 | 31 | 0.030 |
Why?
| Tobacco Products | 1 | 2015 | 110 | 0.030 |
Why?
| Muscle, Skeletal | 1 | 2018 | 750 | 0.030 |
Why?
| Motor Activity | 2 | 2005 | 229 | 0.030 |
Why?
| United States Department of Veterans Affairs | 1 | 2014 | 285 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2013 | 280 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2017 | 976 | 0.030 |
Why?
| Recurrence | 1 | 2014 | 652 | 0.030 |
Why?
| Health Status Disparities | 1 | 2014 | 195 | 0.030 |
Why?
| Behavior Therapy | 1 | 2013 | 181 | 0.020 |
Why?
| Referral and Consultation | 1 | 2013 | 285 | 0.020 |
Why?
| Videotape Recording | 1 | 2011 | 28 | 0.020 |
Why?
| Verbal Behavior | 1 | 2011 | 35 | 0.020 |
Why?
| Midazolam | 1 | 2010 | 38 | 0.020 |
Why?
| Noise | 1 | 2011 | 39 | 0.020 |
Why?
| Homes for the Aged | 1 | 2011 | 33 | 0.020 |
Why?
| Enzyme Induction | 1 | 2010 | 80 | 0.020 |
Why?
| Response Elements | 1 | 2010 | 29 | 0.020 |
Why?
| Chromatin Immunoprecipitation | 1 | 2010 | 49 | 0.020 |
Why?
| Sex Distribution | 1 | 2011 | 134 | 0.020 |
Why?
| Substance Abuse Detection | 1 | 2010 | 92 | 0.020 |
Why?
| Caseins | 1 | 2010 | 80 | 0.020 |
Why?
| Income | 1 | 2010 | 99 | 0.020 |
Why?
| Protein Transport | 1 | 2010 | 180 | 0.020 |
Why?
| Follow-Up Studies | 1 | 2015 | 2182 | 0.020 |
Why?
| Nursing Homes | 1 | 2011 | 114 | 0.020 |
Why?
| Language | 1 | 2011 | 133 | 0.020 |
Why?
| Nicotinic Agonists | 1 | 2009 | 56 | 0.020 |
Why?
| Self Administration | 1 | 2009 | 102 | 0.020 |
Why?
| Administration, Topical | 1 | 2009 | 56 | 0.020 |
Why?
| Secondary Prevention | 1 | 2009 | 78 | 0.020 |
Why?
| Reaction Time | 1 | 2009 | 216 | 0.020 |
Why?
| Regression Analysis | 1 | 2009 | 395 | 0.020 |
Why?
| Self Concept | 1 | 2008 | 63 | 0.020 |
Why?
| Patient Compliance | 1 | 2009 | 230 | 0.020 |
Why?
| Internship and Residency | 1 | 2013 | 443 | 0.020 |
Why?
| RNA, Messenger | 1 | 2010 | 1105 | 0.020 |
Why?
| Audiovisual Aids | 1 | 2007 | 12 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2009 | 903 | 0.020 |
Why?
| Reading | 1 | 2007 | 83 | 0.020 |
Why?
| Prevalence | 1 | 2009 | 944 | 0.020 |
Why?
| Immunoglobulin G | 1 | 2005 | 186 | 0.020 |
Why?
| Behavior, Animal | 1 | 2005 | 181 | 0.010 |
Why?
| Drug Overdose | 1 | 2005 | 159 | 0.010 |
Why?
| Amphetamine | 1 | 2003 | 38 | 0.010 |
Why?
| Tissue Distribution | 1 | 2003 | 163 | 0.010 |
Why?
| Prednisolone | 1 | 2002 | 55 | 0.010 |
Why?
| Osteoporosis | 1 | 2002 | 146 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2005 | 1455 | 0.010 |
Why?
| Cell Survival | 1 | 2002 | 600 | 0.010 |
Why?
| Bone Density | 1 | 2002 | 379 | 0.010 |
Why?
| Bone Resorption | 1 | 2002 | 304 | 0.010 |
Why?
| Osteoblasts | 1 | 2002 | 450 | 0.010 |
Why?
| Brain | 1 | 2003 | 1328 | 0.010 |
Why?
|
|
Landes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|